Clinical Trial Update: A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED) [Phase 1]

View source ↗

Summary

Phase 1 trial of a single-dose MK-3614 has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK-3614

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2019-08-08